Clinical Trials
606 trialsSAH
Ruijin Hospital
AI-Based Risk Prediction Model for Upper Digestive Tract Cancer
National Taiwan University Hospital
A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases
The First Hospital of Jilin University
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
Xijing Hospital
The Gastric Cancer Foundation: A Gastric Cancer Registry
Stanford University
OvAR-Y
Washington University School of Medicine
KITuKo
Medizinische Hochschule Brandenburg Theodor Fontane
Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer
Region Skane
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Hebei Medical University
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
City of Hope Medical Center
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
PREDIPER
Assistance Publique - Hôpitaux de Paris
iCaRe2
University of Nebraska
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
Qilu Hospital of Shandong University
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
MRinRT
Swansea Bay University Health Board
Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
Xijing Hospital of Digestive Diseases
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
Ruijin Hospital
Identification of Therapeutic Targets in Metastatic Gastric Cancer
Chinese University of Hong Kong
XAI-EGC
The First Affiliated Hospital of Soochow University
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
MRD-GC
Peking University
iGreenGO
Niguarda Hospital
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
The University of Texas Health Science Center at San Antonio
StomachCancer
Sohag University
EconROGCAS
Unidade Local De Saúde Do Norte Alentejano
AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer
First Affiliated Hospital of Zhejiang University
DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)
Hebei Medical University
The UGIRA International Registry for RAMIG for Gastric Cancer
Chinese University of Hong Kong
18F-FAPI PET/CT and MRI in Gastric Cancer
First Affiliated Hospital of Zhejiang University
pCLE
Changhai Hospital
SPQUSS-41
Parc de Salut Mar
Hélico-MQ
University Hospital Center of Martinique
ECLIPSE-CG
Société Algérienne de Formation et Recherche en Oncologie
(CLOCS-2)
Imperial College London
IND-PREP
Asian Institute of Gastroenterology, India
GENCONCOR-2
Blokhin's Russian Cancer Research Center
The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
First Affiliated Hospital of Zhejiang University
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
First Affiliated Hospital of Zhejiang University
Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
GASTROBRAIN
Blokhin's Russian Cancer Research Center
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
First Affiliated Hospital of Chongqing Medical University
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
Fudan University
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
CAFÉ
Abramson Cancer Center at Penn Medicine
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
G/GEJ
Fudan University